Multimodal ultrasound assessment of ovarian reserve
- PMID: 41524990
- DOI: 10.1007/s00261-025-05369-x
Multimodal ultrasound assessment of ovarian reserve
Abstract
Ovarian reserve represents the quantity and quality of a woman's remaining oocytes and serves as a key indicator of reproductive potential. Accurate and non-invasive evaluation of ovarian reserve is essential for guiding fertility management, predicting ovarian response, and monitoring age-related or pathological decline. With the advancement of imaging technology, multimodal ultrasound has emerged as a promising tool for comprehensive ovarian assessment. Two-dimensional (2D) and three-dimensional (3D) ultrasound, Doppler imaging, shear wave elastography (SWE), contrast-enhanced ultrasound (CEUS), and artificial intelligence (AI)-driven imaging together provide complementary insights into ovarian morphology, vascularity, and tissue stiffness. These modalities allow quantitative, reproducible, and real-time assessment of ovarian reserve, enabling early detection of diminished ovarian reserve (DOR) and premature ovarian insufficiency (POI). Moreover, AI-assisted analysis enhances diagnostic consistency and efficiency, paving the way for precision reproductive medicine. In conclusion, the integration of multimodal ultrasound technologies offers a comprehensive, non-invasive framework for evaluating ovarian reserve, supporting individualized fertility assessment and improving reproductive outcomes.
Keywords: Autoimmune thyroid diseases (AITD); Contrast-enhanced ultrasound (CEUS); DOR (diminished ovarian reserve); Premature ovarian insufficiency (POI); Shear wave elastography (SWE); Three-dimensional (3D) ultrasound.
© 2026. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical approval: Not applicable. Consent to participate: Not applicable. Consent for publication: All authors have been informed of the article’s content and have provided their consent for its publication.
References
-
- Broekmans FJ, Soules MR, Fauser BC. Ovarian Aging: Mechanisms and Clinical Consequences. Endocrine Reviews. 2009;30:465–93. https://doi.org/10.1210/er.2009-0006 - DOI - PubMed
-
- ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31:926–37. https://doi.org/10.1093/humrep/dew027 - DOI
-
- Pastore LM, Christianson MS, Stelling J, Kearns WG, Segars JH. Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR. J Assist Reprod Genet. 2018;35:17–23. https://doi.org/10.1007/s10815-017-1058-4 - DOI - PubMed
-
- Silva CA, Yamakami LYS, Aikawa NE, Araujo DB, Carvalho JF, Bonfá E. Autoimmune primary ovarian insufficiency. Autoimmunity Reviews. 2014;13:427–30. https://doi.org/10.1016/j.autrev.2014.01.003 - DOI - PubMed
-
- Hu X, Chen Y, Shen Y, Tian R, Sheng Y, Que H. Global prevalence and epidemiological trends of Hashimoto’s thyroiditis in adults: A systematic review and meta-analysis. Front Public Health. 2022;10:1020709. https://doi.org/10.3389/fpubh.2022.1020709 - DOI - PubMed - PMC
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
